Encapsulating peritoneal sclerosis: case series from a university center

被引:9
作者
Hong, Kyung-Deuk
Bae, Ji Hea
Jang, Yun-Jin
Jung, Hee-Yeon
Cho, Jang-Hee
Choi, Ji-Young
Kim, Chan-Duck
Kim, Yong-Lim
Park, Sun-Hee
机构
[1] Department of Internal Medicine, Kyungpook National University Hospital, Daegu
[2] Clinical Research Center for End Stage Renal Disease in Korea, Daegu
[3] Department of Radiology, Kyungpook National University Hospital, Daegu
关键词
HIGH GLUCOSE; RISK-FACTORS; DIALYSIS; JAPAN; COMPLICATION; MULTICENTER; TGF-BETA-1; EXPERIENCE; DIAGNOSIS; OUTCOMES;
D O I
10.3904/kjim.2013.28.5.587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Encapsulating peritoneal sclerosis (EPS) is an often-fatal complication of long-term peritoneal dialysis (PD). We here report the clinical features of EPS in Korean PD patients from a single university center. Methods: The data were collected retrospectively from 606 PD patients at Kyungpook National University Hospital, between August 2001 and August 2011. The diagnosis of EPS was based on clinical signs and symptoms, and confirmed by radiological findings. Results: Eight patients (1.3%, four males) were diagnosed with EPS. The mean age of the patients was 48.5 years (range, 33 to 65). The mean duration of PD was 111.8 months (range, 23 to 186). All patients except for one had three or more episodes of peritonitis. Seven patients were diagnosed with EPS after stopping PD, and only one stayed on PD after initial diagnosis and treatment. Total parenteral nutrition and corticosteroids, in addition to tamoxifen therapy, were used to treat most of the patients, and one patient underwent surgery (adhesiolysis). The overall mortality rate was 50%. Conclusions: EPS is a serious, life-threatening complication in patients on long-term PD. To reduce the incidence and mortality rate of EPS, careful monitoring and early diagnosis is needed.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 28 条
[1]  
Afthentopoulos TB, 1998, ADV RENAL REPLACE TH, V5, P157
[2]   The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis [J].
Balasubramaniam, Gowrie ;
Brown, Edwina A. ;
Davenport, Andrew ;
Cairns, Hugh ;
Cooper, Barbara ;
Fan, Stanley L. S. ;
Farrington, Ken ;
Gallagher, Hugh ;
Harnett, Patrick ;
Krausze, Sally ;
Steddon, Simon .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) :3209-3215
[3]  
Brown EA, 2009, PERITON DIALYSIS INT, V29, P595
[4]   Encapsulating Peritoneal Sclerosis in the New Millennium: A National Cohort Study [J].
Brown, Michaela C. ;
Simpson, Keith ;
Kerssens, Jan J. ;
Mactier, Robert A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (07) :1222-1229
[5]   Encapsulating peritoneal sclerosis: An unpredictable and devastating complication of peritoneal dialysis [J].
Chin, AI ;
Yeun, JY .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) :697-712
[6]  
DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14
[7]  
Eltoum MA, 2006, PERITON DIALYSIS INT, V26, P203
[8]   Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription [J].
Habib, Anne-Marie ;
Preston, Emma ;
Davenport, Andrew .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) :1633-1638
[9]   Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes [J].
Johnson, David W. ;
Cho, Yeoungjee ;
Livingston, Brian E. R. ;
Hawley, Carmel M. ;
McDonald, Stephen P. ;
Brown, Fiona G. ;
Rosman, Johan B. ;
Bannister, Kym M. ;
Wiggins, Kathryn J. .
KIDNEY INTERNATIONAL, 2010, 77 (10) :904-912
[10]  
Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43